46/1 HAPLOTYPE IS ASSOCIATED WITH A HIGHER MONOCYTE/LYMPHOCYTE RATIO IN HEALTHY INDIVIDUALS
Author(s): ,
Gonzalo Carreño-Tarragona
Affiliations:
Haematology,Hospital Universitario 12 de Octubre,Madrid,Spain;Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
,
Juan Carlos Silla
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
,
Belén Oliva
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
,
Andrew J. Chase
Affiliations:
Wessex Regional Genetics Laboratory,Salisbury,United Kingdom
,
Raquel Rouco
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
,
Rosa Ayala
Affiliations:
Haematology,Hospital Universitario 12 de Octubre,Madrid,Spain
,
José Manuel García-Ruiz
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
,
Nicholas C. P. Cross
Affiliations:
Wessex Regional Genetics Laboratory,Salisbury,United Kingdom
,
Joaquín Martínez-López
Affiliations:
Haematology,Hospital Universitario 12 de Octubre,Madrid,Spain
,
Fátima Sánchez-Cabo
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
,
Valentín Fuster
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
Miguel Manzanares
Affiliations:
Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC),Madrid,Spain
EHA Library. Carreno-Tarragona G. Jun 14, 2019; 266463; PF664
Gonzalo Carreno-Tarragona
Gonzalo Carreno-Tarragona
Contributions
×
Abstract

Abstract: PF664

Type: Poster Presentation

Presentation during EHA24: On Friday, June 14, 2019 from 17:30 - 19:00

Location: Poster area

Background
The JAK2 46/1 haplotype was described a decade ago. This haplotype has been clearly associated with a higher risk of developing JAK2 positive myeloproliferative neoplasms (MPNs) and according to some studies also to JAK2 negative MPNs. Nevertheless, the mechanism by which the 46/1 haplotype increases MPN risk has yet to be described. 

Aims
The aim of this study was to further characterize the effects of the 46/1 haplotype on clinical, analytical and gene expression of healthy individuals. This could give us new insights into the association with myeloproliferative neoplasms.

Methods
We haplotyped 509 healthy participants of the PESA (Progression of Early Subclinical Atherosclerosis) Study for the 46/1 haplotype using an endpoint genotyping system. Average age was 48,1 ± 4,08 years old and 86,4% were males. RNAseq data from total blood of these individuals was generated at baseline and 3 years after enrolment in the study. A moderated mixed effects model was used to identify genes which expression changes could be potentially associated with the haplotype of the participants after adjustment by sequencing batch. P-values were corrected for multiple testing. Gene Enrichment Analysis was performed using the web tool Enrichr (we used Human Gene Atlas for Cell Types and GO Biological Process for Ontologies). Comparisons between traditional risk factors with the haplotype were performed using Chi-square or Fisher´s exact test, as appropriate. The association between biochemical measurements with the haplotype were assessed using linear regression model. 

Results

We identified 285 (56%) wild-type homozygous, 186 (36.5%) heterozygous and 38 (7.5%) 46/1 homozygous. No differences due to sex, age or cardiovascular risk factors were identified.

Complete biochemistry and haemogram data was available for all participants. Correlation of 46/1 haplotype with this data identified a significant association with higher monocyte percentage in visit 1 (p=0.036) and lower lymphocyte percentage (p=0.038) in visit 2. Strikingly, we found correlation with a higher monocyte/lymphocyte ratio in both visits (p=0.031 and p=0.032 for visit 1 and 2 respectively). No differences were found in biochemical data between genotypes in either visits.

We next analyzed RNAseq data of total blood for both visits. Comparing 46/1 with wild-type homozygotes we found differences in the expression of 759 (out of 12060) and 871 (out of 12081) genes. For visit 1, 395 genes were upregulated and 364 were downregulated. For visit 2, 350 genes were upregulated and 521 were downregulated. However, these differences were not statistically significant after adjustment for multiple testing.

Nevertheless, we performed a gene enrichment analysis based on functional annotation. In both visits, genes related to the lymphocyte lineage and acquired immunity processes were downregulated while genes related to the myeloid lineage (more specifically monocyte and early erythroid genes) were upregulated (Figure 1).

Conclusion

The 46/1haplotype is associated with an unbalance in monocyte/lymphocyte ratio in healthy individuals. The reason for this is unclear, but may relate to inflammatory processes. Finally, there is an enrichment in expression of genes related to the myeloid lineage in whole blood of 46/1 homozygotes. Our data provides novel insights into the physiological consequences of the 46/1 haplotype and offers new clues in our understanding the pathophysiology of MPNs.

Session topic: 15. Myeloproliferative neoplasms - Biology & Translational Research

Keyword(s): Gene expression profile, Immune response, Myeloproliferative disorder

By continuing to browse or by clicking “Accept Terms & all Cookies”, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies